|
|
Life Science Web SeminarsRecent Web Seminars Model N/Pharmaceutical Commerce Web Seminar - Uncovering Net Revenue: Turning Information into Insight into Income with Revenue Management Intelligence Is it possible to wring more net revenue from sales? Is it possible —finally — to make forecasts based on fresh, up-to-the-minute data? Will you be prepared to manage the complex changes in government pricing, rebates and reimbursements coming out of health care reform legislation. Join Hussain Mooraj of AMR Research, Mark Wiseman of IMS Health, Gopkiran Rao of Model N, and moderator Nick Basta, Editor, Pharmaceutical Commerce to learn more about how innovative pharma manufacturers are using analytics to turn information into insight into income. This panel of heavy-hitting analysts and technology innovators details how Revenue Management solutions from Model N are helping pharma companies gain value and insight from their commercial data. New analytics tools are enabling deeper insights into performance metrics and managed market trends, as well as delivering powerful predictive revenue modeling capabilities.
CBI/Model N Web Seminar: Practical Strategies and Solutions for Managing GP and MDRP Impacts of Health Care Reform This complimentary CBI/Model N Web Seminar is designed to arm participants with questions to consider, best practice recommendations, and strategies relating to health care reform. Model N Regulatory Senior Product Manager Scott Medberry will be joined by King & Spalding partner John Shakow and Hospira director of compliance and price reporting Lynn Leone to discuss the key new provisions, relevant lessions from past regulatory mandates, and how to drive an effective tactical and strategic response to the new legislation. View Recording Model N Release 5.4 Overview CBI/Model N Web Seminar: Leveraging Revenue Management Analytics to Formulate Successful Pricing and Contracting Strategies in Pharma Revenue Management Best Practices for Managed Care Contracting ![]() This Web seminar offers an analysis of the key industry trends in the managed care arena as identified in Model N's 2007 Managed Care and Medicare Part D Industry Benchmark Survey. Industry experts outline crucial manufacturer challenges relating to pricing, rebate programs, financial payments, and regulatory compliance while offering practical recommendations for pharmaceutical executives looking to address the issues impacting this critical area of their revenue strategy. View Recording
Maximizing Order to Cash Impact with Proven Approaches to Integrating Revenue Management
Making the Medicaid Drug Rebate Program Work for You |
Quick Links
|


